I am a WAG pharmacist and from where I am standing back there dispensing your medications, I can tell you the majority of folks getting these SGLT2 Inhibitors (the ozempics, wegovy etc) are not getting them for superficial reasons. they are mostly morbidly obese patients with a myriad of comorbid conditions such as diabetes, heart disease etc. and these injections work, unsurprisingly well. And i don't see a crackdown on doctors writing them, because they aren't narcotics or a controlled substance. Even phentermine which was a weight loss drug as well and was a controlled substance wasn't on the DEA's list like that. the worst that can happen is insurance not wanting to pay for them but even that is 50/50.
Also, the benefits that these medications have shown in terms of improving patient outcomes hasn't gone over the heads of beleaguered insurance companies who have been trying to find ways to save money for quite some time now. I think i heard a few months back that some medicaid plans were planning on covering them and think about it.
If you were an insurance company exec, wouldnt you rather cover ozempic for your 400lb insuree who has type 2 diabetes, an LDL of 300, Total cholesterol of 350 and by all indications in about 4 years may end up having a stroke, heart attack or kidney failure?
Pay for their ozempic for about 6 months, they lose 150 lbs (I have seen this in person many times) and with that weight loss, all the other comorbities also go down in severity...in the long run you save your company millions.